Course Objectives

  • Review the “true data” from the WHI, with the significant outcomes that impact our treatment of women in relation to HRT replacement therapy

  • Learn the importance of testosterone in breast health, as well as its implications in treating women with history of or active breast cancer

  • Discuss the different treatment options for Genitourinary Symptoms of Menopause, as well as the safe treatment options for breast cancer patients

  • Learn which BHRT options may be safe and effective in breast cancer patients or those with a high-risk background or history

Course curriculum

  • 1

    Welcome

    • Welcome to Management Considerations for Patients with Risk Of or Diagnosis Of Breast Cancer

  • 2

    Part 1: Breast Cancer Risks and Development

    • Breast Cancer Risks and Development lecture (36:13)

    • Breast Cancer Risks and Development- PDF

  • 3

    Part 2: Genitourinary Syndromes and Possible Treatments for Best Outcomes

    • Genitourinary Syndromes and Possible Treatments for Best Outcomes lecture (12:57)

    • Genitourinary Syndromes and Possible Treatments for Best Outcomes- PDF

  • 4

    Part 3: Management Strategies

    • Management Strategies lecture (26:59)

    • Management Strategies- PDF

  • 5

    Breast Cancer Reference Articles

    • Glaser 2021-Testosterone Implant Therapy in Women With and Without Breast Cancer: Rationale, Experience, Evidence

    • Chelbowski 2021-Breast Cancer Prevention: Time for a Change

    • Glaser 2013- Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole:A prospective, observational study

    • Tan 2022- Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk

    • Glaser 2019- Incidence of invasive breast cancer in women treated with testosterone implants: a prospective 10-year cohort study

    • Hodis 2018-Menopausal hormone therapy and breast cancer what is the evidence from randomized trials

    • Feng 2018- Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis

    • Donovitz 2021- Breast Cancer Incidence Reduction in Women Treated with Subcutaneous Testosterone: Testosterone Therapy and Breast Cancer Incidence Study

    • Longer 2017-What Are We To Believe

  • 6

    Management Considerations for Breast Cancer Quiz

    • Breast Cancer Management Quiz

Instructor(s)

HRT Expert, Author, Speaker, Entrepreneur

Angela DeRosa DO, MBA, CPE

Dr. Angela DeRosa, Medical Director for Belmar Pharma Solutions is a respected, internationally recognized authority on women’s hormonal health. Dr. DeRosa has more than 25 years of experience in pharmaceuticals, clinical practice, and education. A board-certified internist specializing in women’s health and hormonal health for men and women, Dr. DeRosa is the Founder of DeRosa Medical, DRM Integrative Health, and Revive Wellness, where she treated over twenty thousand patients using advanced BHRT optimization. Dr. DeRosa is also an accomplished author, professor, lecturer, and published researcher as well as the founder of the Hormonal Health Institute. Dr. DeRosa received a Doctorate of Osteopathic Medicine from Midwestern University as well as a Master’s in Medical Management from Amherst College.